CD19 and leukemia: Recently, Deniger et al. have transduced polyclonal γδ T cells with a CD19-specific CAR, demonstrating their efficacy in killing CD19+ leukaemia lines.87 CAR-mediated signalling resulted in a similar cytokine secretion profile as TCR activation, and induced unbiased expansion of γδ T cell subsets.